D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Parkinson s Disease · Parkinson Disease (PD)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Nevro Arendal Soerlandsklinikken, Arendal, Agder, Norway

    Contact: Study coordinator (Karen Herlofson, MD, PhD) · Karen.Herlofson@nevroarendal.no
    Contact: Principal Investigator (Karen Herlofson, MD, PhD)
  • Akershus University Hospital, Lørenskog, Akershus, Norway

    Contact: Study coordinator (Krisztina Kunszt Johansen, MD, PhD) · krisztina.johansen@ahus.no
    Contact: Principal Investigator (Krisztina Kunszt Johansen, MD, PhD)
  • Vestre Viken Hospital, Drammen, Buskerud, Norway

    Contact: Study coordinator (Kari Anne Bjørnarå, MD, PhD) · kari.anne.bjornara@vestreviken.no
    Contact: Principal Investigator (Kari Anne Bjørnarå, MD, PhD)
  • Molde Hospital, Molde, Møre og Romsdal, Norway

    Contact: Study coordinator (Eldbjørg Hustad, MD, PhD) · Eldbjorg.Hustad@helse-mr.no
    Contact: Principal Investigator (Eldbjørg Hustad, MD, PhD)
  • Bodø Hospital (Nordland Hospital), Bodø, Nordland, Norway

    Contact: Study coordinator (Espen Benjaminsen, MD, PhD) · Epen.benjaminsen@nordlandssykehuset.no
    Contact: Principal Investigator (Espen Benjaminsen, MD, PhD)
  • Oslo University Hospital, Oslo, Oslo, Norway

    Contact: Study coordinator (Lasse Pihlstrøm, MD, PhD) · lasse.pihlstrom@medisin.uio.no
    Contact: Principal Investigator (Lasse Pihlstrøm, MD, PhD)
  • Haugesund Hospital, Haugesund, Rogaland, Norway

    Contact: Study coordinator (Roelfien Ida HøgenEsch, MD, PhD) · roelfien.ida.hogenesch@helse-fonna.no
    Contact: Principal Investigator (Roelfien Ida HøgenEsch, MD, PhD)
  • University Hospital of North Norway, Tromsø, Troms, Norway

    Contact: Study coordinator (Hallvard Lilleng, MD, PhD) · Hallvard.Lilleng@unn.no
    Contact: Principal Investigator (Hallvard Lilleng, MD, PhD)
  • Haukeland University Hospital, Bergen, Vestland, Norway

    Contact: Study coordinator (Charalampos Tzoulis, MD, PhD) · charalampos.tzoulis@helse-bergen.no · 55975061
    Contact: Study coordinator (Haakon Berven, MD) · haakon.berven@helse-bergen.no · 55755045
    Contact: Principal Investigator (Haakon Berven, MD)
    Contact: Principal Investigator (Geir Olve Skeie, MD, PhD)
  • Førde Hospital, Førde, Vestland, Norway

    Contact: Study coordinator (Aliaksei Labusau, MD, PhD) · aliaksei.labusau@helse-forde.no
    Contact: Principal Investigator (Aliaksei Labusau, MD, PhD)
  • Østfold Hospital, Sarpsborg, Østfold fylke, Norway

    Contact: Study coordinator (Gabriela Fortes, MD) · Gabriela.Fortes@so-hf.no
    Contact: Principal Investigator (Gabriela Fortes, MD)